Sol-Gel Technologies Ltd.
IPOHarnessing Dermatological Innovation
Sol-Gel Technologies Ltd. is a biotech company in Ness Ziona. It has 2 recorded funding rounds.
- Headquarters
- Ness Ziona
- Business Model
- B2B
- Website
- sol-gel.com
- Rounds
- 2
- Type
- Public
Indexed holds 2 funding rounds and 4 investors for this company. to use credits for reveals, or explore the API.
About
Sol-Gel Technologies is a NASDAQ-listed (SLGL) dermatology company leveraging proprietary microencapsulation and formulation technology to develop and commercialize advanced treatments for patients with severe and rare skin conditions, including two FDA-approved products, TWYNEO and EPSOLAY. The company's pipeline extends into additional indications such as Gorlin Syndrome and high-frequency basal cell carcinoma, and it partners with established commercial leaders to accelerate global product rollout.
Funding & Exit History
May 2026
5 more events
- Secondary Market2023
- Secondary Market2020
- IPO2018
Funding, valuations, and company events, with amounts and investors where available.
Investors
Companies in related industries
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sol-gel-technologies-ltd"><img src="https://indexed.vc/api/badge/company/sol-gel-technologies-ltd" alt="Sol-Gel Technologies Ltd. on Indexed.vc" width="260" height="76" /></a>